The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke
NCT ID: NCT06354881
Last Updated: 2025-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
75 participants
OBSERVATIONAL
2024-05-02
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Head Position on Cerebral Haemodynamics in Acute Ischemic Stroke and Controls
NCT02932540
Ischaemic Lesions in Acute Intracerebral Haemorrhage
NCT06410274
Cognitive Impairment and Cerebral Haemodynamics in Individuals With Symptomatic Peripheral Arterial Disease
NCT06369402
Validation of 3D Simulations in Embolic Stroke
NCT05055960
Comparison of Ultrasound Cerebral Perfusion Imaging With Routine Perfusion CT
NCT07324421
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cerebral autoregulation (CA) plays a large part in regulating cerebral blood flow (CBF), through maintaining cerebral perfusion, even with fluctuating BP. It does this by regulating the cerebral vasculature through adjustments in vessel diameter. CA has been assessed at rest and challenged with paradigms in healthy volunteers and lacunar stroke patients, however comparisons between younger and older lacunar events incorporating risk factors has not been looked at. The difference in CA phenotype between those with uncontrolled high-risk cardiometabolic factors (often younger patients) and those with moderate/severe small vessel disease and recurrent lacunar stroke syndromes (often older patients) is unknown. Therefore, exploring different risk factors and the different lacunar disease phenotypes is important to identify any differences in cerebral haemodynamics.
Assessing dynamic CA (dCA) in response to fluctuations in BP represents how CA responds to BP fluctuations in the body, allowing better application to the human vasculature, compared to assessing static CA. Multiple paradigms and manoeuvres have been used to assess dCA by inducing a rapid change in BP, but both patient tolerability and ability to measure dCA accurately need to be considered for this study. The sit-stand manoeuvre is a clinically applicable manoeuvre which can be done both in the ward and laboratory with minimal stress to the patient. This manoeuvre has been evaluated in a published review and compared to a thigh-cuff technique which has been used extensively in previous research. The thigh-cuff technique induces a rapid change in arterial blood pressure (ABP) through the rapid deflation of the thigh cuff. However, this repeated action can be painful for some participants making it difficult to apply clinically to frail patients leading to issues of unsuccessful repeats. The review found that autoregulatory index (ARI) values were similar across both the sit-stand and thigh-cuff manoeuvres, showing sit-stand is an accurate manoeuvre to measure CA. The sit-stand manoeuvre was also better tolerated compared to the thigh-cuff.
Following up patients post-stroke as high-risk factors are controlled will help understand changes in CA and could help guide the timing of interventions to manipulate BP and potentially for the impact of rehabilitation programmes.
Lacunar stroke is one of the most common types of stroke, occurring in both younger and older generations. Some studies have observed impaired brain blood flow regulation (cerebral autoregulation) in a cohort of \~57 years of age (median), which has also been seen in those with small vessel disease. Small vessel disease is often seen in older patients who often present with recurrent lacunar strokes despite earlier management of risk factors.
By targeting a younger cohort with uncontrolled risk factors (hypertension and diabetes), the investigators aim to perform a more comprehensive study to investigate the haemodynamic consequences of lacunar strokes in this group. This would be done by using Transcranial Doppler ultrasound (TDC) to measure CBv in patients who are diagnosed with a lacunar stroke and have undiagnosed diabetes and/or hypertension at their initial appointment. To measure a dCA response, the sit-stand manoeuvre will be used. These patients would then receive management of their risk-factors and would be asked to undergo another TCD assessment 4 weeks after their initial appointment. Data would be collected and analysed to look at any differences in cerebral haemodynamics between before and after management of such risk factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lacunar Stroke Syndrome Patients
Patients who have been diagnosed with lacunar stroke syndrome. This is a non-intervention study so no intervention will be given. However, the investigators will observe the changes in cerebral haemodynamics of this group before and after they have been given medications to help control hypertension and/or diabetes which are common risk factors of lacunar stroke syndrome.
Transcranial Doppler Ultrasonography (TCD) during sit-stand manoeuvres
TCD will be used to measure the cerebral blood flow in the middle and posterior cerebral arteries. This will be done at rest and during two sit-stand manoeuvres, whereby the participant will be asked to stand (from a seated position) and stay standing for 1 minute. The participant will then be given time to recover before repeating the manoeuvre. This will occur at the first visit and the follow-up visit 4 weeks after.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Doppler Ultrasonography (TCD) during sit-stand manoeuvres
TCD will be used to measure the cerebral blood flow in the middle and posterior cerebral arteries. This will be done at rest and during two sit-stand manoeuvres, whereby the participant will be asked to stand (from a seated position) and stay standing for 1 minute. The participant will then be given time to recover before repeating the manoeuvre. This will occur at the first visit and the follow-up visit 4 weeks after.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of lacunar stroke syndrome.
* New diagnosis or known diagnosis of hypertension and/or diabetes.
Exclusion Criteria
* Those with poorly controlled medical comorbidities affecting cerebral haemodynamics. (eg., heart failure).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Heart Foundation
OTHER
University Hospitals, Leicester
OTHER
University of Leicester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Leicester NHS Trust
Leicester, Leicestershire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TM61008S3
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
0967
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.